A Nomination Committee consisting of members appointed by the three largest shareholders or group of shareholders has been formed for Biotage AB in accordance with the principles adopted by the annual general meeting held on 25 April 2024. The Nomination Committee shall, before the Annual General Meeting 2025, prepare proposal for the election of Chairman and other members of the Board of Directors, the election of Chairman of the Annual General Meeting, election of Auditors, the determination of fees and matters pertaining thereto.
The members of the Nominations Committee are:
Shareholders wishing to submit a proposal to the Nomination Committee may do so by sending e-mail to the Chairman of the Board of Directors of Biotage AB at: info@biotage.com. Proposals should, in order to be timely assessed by the Nomination Committee, be submitted no later than seven weeks in advance of the meeting.
The Annual General Meeting 2025 in Biotage will be held on Thursday, April 24, 2025 at 11:00am CET in Uppsala. Shareholders who want to have a matter addressed at the Annual General Meeting 2025 must submit such a proposal to the same address as above (subject “Annual General Meeting 2025” for the e-mail and the letter, respectively) seven weeks in advance of the meeting at the latest.
Biotage is the Global Go-To Separations Company, supporting customers from drug discovery and development through to diagnostics and analytical testing with intelligent and sustainable workflow solutions. Our expertise and top-tier separation solutions play a key role in streamlining our customers’ workflows and improving their outcomes. Headquartered in Sweden, Biotage operates globally with 700 employees, serving over 80 countries. Our company is listed on NASDAQ Stockholm (BIOT).
Copyright © 2024 Biotage
Biotage är ett Globalt Go-To Separations-företag, som stödjer kunder inom forskning och tillverkning av läkemedel, diagnostik och analytiska tester, med intelligenta och hållbara arbetsflödeslösningar. Vår expertis och våra högkvalitativa separationslösningar spelar en nyckelroll för att effektivisera kunders arbetsflöden och förbättra deras resultat. Biotage har sitt huvudkontor i Sverige, 700 medarbetare globalt, och levererar lösningar till över 80 länder. Vårt företag är noterat på NASDAQ Stockholm (BIOT).
Copyright © 2020 Biotage
SEL-2EV
Two Channel, Extended Collection Bed, UV Detector